2,702 results on '"Abraham, William T."'
Search Results
202. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure
203. Improved Algorithm to Detect Fluid Accumulation via Intrathoracic Impedance Monitoring in Heart Failure Patients With Implantable Devices
204. Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction
205. Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 2—Use in Automated Detection
206. Hemodynamic Factors Associated With Acute Decompensated Heart Failure: Part 1—Insights into Pathophysiology
207. CHAMPION Trial Rationale and Design: The Long-Term Safety and Clinical Efficacy of a Wireless Pulmonary Artery Pressure Monitoring System
208. Epidemiology of Sudden Cardiac Death in Patients with Heart Failure
209. Telemedicine and remote management of patients with heart failure
210. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
211. A Polymorphism within a Conserved β₁-Adrenergic Receptor Motif Alters Cardiac Function and β-Blocker Response in Human Heart Failure
212. Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial
213. Abstract 12124: A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
214. Abstract 10685: Right Ventricular-Pulmonary Arterial Coupling in Heart Failure Patients with Secondary Mitral Regurgitation: Analysis from the COAPT Trial
215. Renal Salt and Water Handling in Congestive Heart Failure
216. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
217. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial
218. Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial.
219. Remote Heart Failure Monitoring
220. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics
221. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy
222. Reproducibility of Peak Oxygen Uptake and Other Cardiopulmonary Exercise Parameters: Implications for Clinical Trials and Clinical Practice
223. Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial
224. Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial
225. Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure
226. Early Reduction in Ambulatory Pulmonary Artery Pressures After Initiation of Sacubitril/Valsartan
227. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials
228. Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunction
229. In-Hospital Treatment of Obstructive Sleep Apnea During Decompensation of Heart Failure
230. Financial strain, inflammatory factors, and haemoglobin A1c levels in African American women
231. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
232. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium
233. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium
234. Reduction in ventricular arrhythmias and mortality in the primaries: a real-life win–win for CRT-Ds?
235. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure
236. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
237. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
238. In-hospital Testing for Sleep-disordered Breathing in Hospitalized Patients With Decompensated Heart Failure: Report of Prevalence and Patient Characteristics
239. The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network
240. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
241. Heart failure
242. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: Findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
243. Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea
244. Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF)
245. A current and future outlook on upcoming technologies in the remote monitoring of patients with heart failure
246. Trials of implantable monitoring devices in heart failure: which design is optimal?
247. Implantable Cardiovascular Sensors and Computers: Interventional Heart Failure Strategies
248. Feasibility of remote speech analysis in evaluation of dynamic fluid overload in heart failure patients undergoing haemodialysis treatment
249. Interatrial shunting for the treatment of heart failure: an on‐demand , self‐regulating left atrial pressure lowering system
250. Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.